跳至主要内容
临床试验/NCT07404657
NCT07404657尚未招募不适用

Preliminary Assessment of iCare RETCAD as an Automated Tool for Diabetic Retinopathy Screening

Centervue SpA0 个研究点目标入组 198 人开始时间: 2026年2月1日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
Centervue SpA
入组人数
198
主要终点
Number of subjects whose results provided by the automatic AI-based tool match the reading center grading for the identification of referable diabetic eye disease (more than mild DR).

研究概览

简要总结

This study is being done to evaluate the performance of a software that uses artificial intelligence to analyze photographs of the retina to help detect diabetic retinopathy. The study will also assess the safety of the software in combination with a fundus camera already available on the market. This software analyzes retinal photographs to detect more than mild diabetic retinopathy in adults with diabetes. The results will be compared to expert human evaluations.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Cross Sectional

入排标准

年龄范围
22 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 22 years old or older
  • diabetes or diabetic retinopathy
  • understand the study information and able to sign a consent form

排除标准

  • cannot tolerate eye imaging tests
  • laser treatment or injections
  • eye surgery, except for simple cataract surgery
  • currently involved in another study
  • cannot or do not want to have your eyes dilated
  • photodynamic therapy within the last 90 days

结局指标

主要结局

Number of subjects whose results provided by the automatic AI-based tool match the reading center grading for the identification of referable diabetic eye disease (more than mild DR).

时间窗: 1-day visit

次要结局

  • percentage of eyes for which the AI-based automatic tool produced a result(1-day visit)

研究者

发起方
Centervue SpA
申办方类型
Industry
责任方
Sponsor

相似试验